Abstract
In this issue of Blood, Ruppert and colleagues compare 3 common prognostic indices for diffuse large B-cell lymphoma (DLBCL) across a large assemblage of patients in clinical trials and argue that the National Comprehensive Cancer Network (NCCN) International Prognostic Index (IPI) performs best.
Cite
CITATION STYLE
APA
Link, B. K. (2020, June 4). Foreseeing what is to happen in DLBCL. Blood. American Society of Hematology. https://doi.org/10.1182/BLOOD.2020005678
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free